These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12578515)

  • 1. Sedative use in the last week of life and the implications for end-of-life decision making.
    Sykes N; Thorns A
    Arch Intern Med; 2003 Feb; 163(3):341-4. PubMed ID: 12578515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of opioids and sedatives at the end of life.
    Sykes N; Thorns A
    Lancet Oncol; 2003 May; 4(5):312-8. PubMed ID: 12732169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.
    Schildmann E; Pörnbacher S; Kalies H; Bausewein C
    Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical ethics and double effect: the case of terminal sedation.
    Boyle J
    Theor Med Bioeth; 2004; 25(1):51-60. PubMed ID: 15180095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Terminal sedation in mentally competent patients: no overriding medical-ethical arguments against in the medical literature].
    van Deijck RH; Rondas AA; Berghmans RL
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2479-83. PubMed ID: 14708215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The double life of double effect.
    McIntyre A
    Theor Med Bioeth; 2004; 25(1):61-74. PubMed ID: 15180096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: Findings from focus groups and patient records for I-CAN-CARE.
    Vivat B; Bemand-Qureshi L; Harrington J; Davis S; Stone P
    Palliat Med; 2019 Jun; 33(6):578-588. PubMed ID: 30747052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Palliative sedation, the sympathetic alternative for euthanasia?].
    Keizer AA; Swart SJ
    Ned Tijdschr Geneeskd; 2005 Feb; 149(9):449-51. PubMed ID: 15771337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying?
    Giles A; Sykes N
    Palliat Med; 2017 Jan; 31(1):89-92. PubMed ID: 27247086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use in last week of life and implications for end-of-life decision-making.
    Thorns A; Sykes N
    Lancet; 2000 Jul; 356(9227):398-9. PubMed ID: 10972375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical decision process applied to the terminal sedation. Ethical analysis].
    Azulay Tapiero A
    Med Clin (Barc); 2004 Mar; 122(9):345-8. PubMed ID: 15033056
    [No Abstract]   [Full Text] [Related]  

  • 12. [Do we need a more precise definition of what sedation is?].
    Sanz Rubiales Á; Barón Duarte F; del Valle Rivero ML
    Cuad Bioet; 2015; 26(86):111-6. PubMed ID: 26030016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narratives of 'terminal sedation', and the importance of the intention-foresight distinction in palliative care practice.
    Douglas CD; Kerridge IH; Ankeny RA
    Bioethics; 2013 Jan; 27(1):1-11. PubMed ID: 21726263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol.
    Padmanabhan U; Leslie K; Eer AS; Maruff P; Silbert BS
    Anesth Analg; 2009 Nov; 109(5):1448-55. PubMed ID: 19617584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life.
    Vitetta L; Kenner D; Sali A
    Am J Hosp Palliat Care; 2005; 22(6):465-73. PubMed ID: 16323717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of midazolam and haloperidol in cancer patients at the end of life.
    Radha Krishna LK; Poulose VJ; Goh C
    Singapore Med J; 2012 Jan; 53(1):62-6. PubMed ID: 22252186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-of-life decisions and the reinvented Rule of Double Effect: a critical analysis.
    Lindblad A; Lynöe N; Juth N
    Bioethics; 2014 Sep; 28(7):368-77. PubMed ID: 23025921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical validity of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.
    Morita T; Chinone Y; Ikenaga M; Miyoshi M; Nakaho T; Nishitateno K; Sakonji M; Shima Y; Suenaga K; Takigawa C; Kohara H; Tani K; Kawamura Y; Matsubara T; Watanabe A; Yagi Y; Sasaki T; Higuchi A; Kimura H; Abo H; Ozawa T; Kizawa Y; Uchitomi Y;
    J Pain Symptom Manage; 2005 Oct; 30(4):308-19. PubMed ID: 16256895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative Sedation at the End of Life: Patterns of Use in an Israeli Hospice.
    Azoulay D; Shahal-Gassner R; Yehezkel M; Eliyahu E; Weigert N; Ein-Mor E; Jacobs JM
    Am J Hosp Palliat Care; 2016 May; 33(4):369-73. PubMed ID: 25701661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory pain, existential suffering, and palliative care: releasing an unbearable lightness of being.
    Smith GP
    Cornell J Law Public Policy; 2011; 20(3):469-532. PubMed ID: 25330560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.